COTY COTY INC.
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1024305 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.2%
TTM net income YoY-47.1%
TTM EPS YoY-41.3%
Revenue 3-yr CAGR-0.1%
Net income 3-yr CAGR—
Margins
Gross margin62.6%
Operating margin-1.7%
Net margin-9.7%
FCF margin7.3%
EBITDA margin6.5%
Returns
ROE-16.7%
ROA-5.0%
ROIC (approx.)-1.2%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets66.4%
Debt / equity0.89x
Current ratio0.75x
Interest coverage-0.57x
Cash quality & payout
Operating cash flow / net income-1.07x
Accruals ratio-10.4%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $5.81B | $5.89B |
| Cost of revenue | $2.15B | $2.07B |
| Gross profit | $3.65B | $3.82B |
| R&D expense | $121.20M | $123.00M |
| SG&A expense | $3.11B | $3.10B |
| Operating income | -$81.50M | $241.10M |
| Interest expense | $184.20M | $227.00M |
| Pretax income | -$610.20M | -$344.80M |
| Income tax | -$20.00M | $5.40M |
| Net income | -$604.80M | -$367.90M |
| EBITDA | $400.70M | $661.10M |
| EPS (basic) | -0.70 | -0.44 |
| EPS (diluted) | -0.70 | -0.44 |
| Weighted avg. shares (diluted) | 877.40M | 870.90M |
| Balance sheet | ||
| Cash & equivalents | $176.10M | $270.40M |
| Receivables | $525.80M | $526.40M |
| Inventory | $838.70M | $794.50M |
| Current assets | $1.92B | $1.95B |
| PP&E, net | $650.00M | $709.20M |
| Goodwill | $3.81B | $4.06B |
| Intangibles | $2.78B | $3.21B |
| Total assets | $10.20B | $11.91B |
| Current liabilities | $2.54B | $2.54B |
| Short-term debt | $14.40M | $3.50M |
| Long-term debt | $3.03B | $3.96B |
| Total debt | $3.05B | $3.96B |
| Total liabilities | $6.82B | $7.95B |
| Shareholders' equity | $2.99B | $3.54B |
| Net debt | $2.87B | $3.69B |
| Shares outstanding | 880.50M | 872.30M |
| Cash flow statement | ||
| Operating cash flow | $537.80M | $492.60M |
| Capital expenditure | $189.60M | $215.00M |
| Free cash flow | $348.20M | $277.60M |
| Investing cash flow | $539.00M | -$128.40M |
| Financing cash flow | -$1.16B | -$426.80M |
| Depreciation & amortization | $482.20M | $420.00M |
| Stock-based compensation | $46.30M | $50.00M |
Free plan shows the latest 2 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.